FDA.reportPublic FDA data

mounjaro 5 MG in 0.5 ML Injection

RxCUI
2644403
RxNorm name
mounjaro 5 MG in 0.5 ML Injection
Display name
mounjaro 5 MG in 0.5 ML Injection
Full name
mounjaro 5 MG in 0.5 ML Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:22

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
d2d7da5d-ad07-4228-955f-cf7e355c8cc0mounjaro 5 MG in 0.5 ML InjectionPSN38These highlights do not include all the information needed to use MOUNJARO safely and effectively. See full prescribing information for MOUNJARO. MOUNJARO ® (tirzepatide) Injection, for subcutaneous use Initial U.S. Approval: 202220260422
d2d7da5d-ad07-4228-955f-cf7e355c8cc00.5 ML tirzepatide 10 MG/ML Injection [Mounjaro]SBD38These highlights do not include all the information needed to use MOUNJARO safely and effectively. See full prescribing information for MOUNJARO. MOUNJARO ® (tirzepatide) Injection, for subcutaneous use Initial U.S. Approval: 202220260422
d2d7da5d-ad07-4228-955f-cf7e355c8cc00.5 ML Mounjaro 10 MG/ML InjectionSY38These highlights do not include all the information needed to use MOUNJARO safely and effectively. See full prescribing information for MOUNJARO. MOUNJARO ® (tirzepatide) Injection, for subcutaneous use Initial U.S. Approval: 202220260422
d2d7da5d-ad07-4228-955f-cf7e355c8cc0Mounjaro 5 MG per 0.5 ML InjectionSY38These highlights do not include all the information needed to use MOUNJARO safely and effectively. See full prescribing information for MOUNJARO. MOUNJARO ® (tirzepatide) Injection, for subcutaneous use Initial U.S. Approval: 202220260422